戻る Agenda
Session 6 Track 3: Mission Launching: Navigating the Challenges to Drive Success
Session Chair(s)
Paul Minne, PharmD, RPh
Senior Director, MSL Team
Neurocrine Biosciences, United States
Almost overnight, working virtually has changed how MSL teams and their leadership tackle medical strategies and initiatives while at the same time keeping their value proposition high. MSLs are frequently shifting gears to build KOL relationships, remap and profile territories, train and certify on new and existing products, and keep up with complex and shifting compliance regulations. This session will take a case series approach to these common tactics and present strategies and practical solutions to overcome barriers to success.
Learning Objective : At the conclusion of this session, participants should be able to:
- Apply new ways of creating value beyond the face to face meeting
- Develop new ideas and plans for launching new products and team initiatives
- Evaluate priorities around the strategic plan when new challenges arise in the virtual world
Speaker(s)
Speaker
Kent Christopherson, PhD
Orchard Therapeutics, United States
Executive Director & Head, Global Medical Affairs
Speaker
Kathleen Doucette, PhD
Amgen Inc., United States
Director, MSLs
Speaker
Monica Guillory, PharmD
Neurocrine Biosciences, United States
Senior Manager, Medical Affairs Training